HEMANGEOL

Drug Pierre Fabre Pharmaceuticals, Inc.
Total Payments
$167,044
Transactions
672
Doctors
390
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $53,230 159 80
2023 $58,580 197 132
2022 $22,526 114 97
2021 $26,243 136 112
2020 $6,466 66 49

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $83,188 54 49.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $27,377 15 16.4%
Honoraria $23,700 13 14.2%
Food and Beverage $23,030 588 13.8%
Grant $5,000 1 3.0%
Consulting Fee $4,750 1 2.8%

Top Doctors Receiving Payments for HEMANGEOL

Doctor Specialty Location Total Records
, MD Pediatric Dermatology San Antonio, TX $11,550 18
, M.D Student in an Organized Health Care Education/Training Program Phoenix, AZ $9,221 23
, M.D Pediatric Dermatology Charleston, SC $7,664 7
, M.D Dermatology Dorado, PR $7,586 5
, MD Dermatology Palo Alto, CA $5,750 7
, MD Pediatric Dermatology Chapel Hill, NC $5,616 5
, M.D Dermatology Columbus, OH $5,377 7
, M.D Dermatology Philadelphia, PA $5,328 7
, PNP Pediatric Anesthesiology Los Angeles, CA $5,280 8
, MD Dermatology Miami, FL $5,274 3
Unknown Northbrook, IL $5,000 1
, MD Dermatology Orlando, FL $4,966 6
, M.D Dermatology Charleston, SC $4,923 7
, CPNP-PC Nurse Practitioner Washington, DC $4,802 7
, MD Internal Medicine Chicago, IL $4,750 1
, M.D Otolaryngology Norfolk, VA $4,309 7
, M.D Pediatric Dermatology Phoenix, AZ $4,289 16
, CPNP Pediatrics Atlanta, GA $4,251 4
, M.D Pediatric Dermatology Bellaire, TX $3,853 6
, MD Pediatrics Charlotte, NC $3,763 7
, MD Pediatrics Greenville, SC $3,719 7
, MD Dermatology New Hyde Park, NY $3,536 6
, MD Dermatology New Haven, CT $3,282 6
, M.D Dermatology Marlton, NJ $2,634 5
, CPNP-PC Pediatrics Phoenix, AZ $2,343 4

About HEMANGEOL

HEMANGEOL is a drug associated with $167,044 in payments to 390 healthcare providers, recorded across 672 transactions in the CMS Open Payments database. The primary manufacturer is Pierre Fabre Pharmaceuticals, Inc..

Payment data is available from 2020 to 2024. In 2024, $53,230 was paid across 159 transactions to 80 doctors.

The most common payment nature for HEMANGEOL is "Travel and Lodging" ($83,188, 49.8% of total).